Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Mohd Haider

Telomir Pharma Skyrockets Nearly 139% After-Hours As Cancer Drug Shows Breakthrough Results, Beats Chemo In Human Cell Tests

After,News,Of,Covid,19,Vaccine,Production,Came,Out,,The

Telomir Pharmaceuticals Inc (NASDAQ:TELO) experienced an increase of 138.84% in its stock value during after-hours trading on Thursday, noting a regular trading session surge of 5.22% to reach $1.21.

What Happened: The surge in stock value followed the announcement of promising data regarding the company’s lead candidate, Telomir-1. The data indicated that Telomir-1 could reverse epigenetic gene silencing, restoring the tumor suppressor in human prostate cancer cells. This performance surpassed that of chemotherapy and rapamycin.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.